As the global economy mends, the 2021 growth of Dermatological OTC Drugs will have significant change from previous year. According to our (Publisher) latest study, the global Dermatological OTC Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Dermatological OTC Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Dermatological OTC Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Dermatological OTC Drugs market, reaching US$ million by the year 2028. As for the Europe Dermatological OTC Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Dermatological OTC Drugs players cover Perrigo Company plc, Bausch Health Companies Inc., Dr. Reddy's Laboratories, and Johnson and Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatological OTC Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Acne Medications
Dermatitis Drugs
Fungal Infection Drugs
Segmentation by distribution channel: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Online Distribution
Offline Distribution
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Perrigo Company plc
Bausch Health Companies Inc.
Dr. Reddy's Laboratories
Johnson and Johnson
Bayer AG
GlaxoSmithKline plc.
Viatris Inc
LEO Pharma A/S
Acella Pharmaceuticals, LLC
Teva Pharmaceutical Industries Ltd.
Galderma
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatological OTC Drugs Market Size 2017-2028
2.1.2 Dermatological OTC Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Dermatological OTC Drugs Segment by Type
2.2.1 Acne Medications
2.2.2 Dermatitis Drugs
2.2.3 Fungal Infection Drugs
2.3 Dermatological OTC Drugs Market Size by Type
2.3.1 Dermatological OTC Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Dermatological OTC Drugs Market Size Market Share by Type (2017-2022)
2.4 Dermatological OTC Drugs Segment by Distribution Channel
2.4.1 Online Distribution
2.4.2 Offline Distribution
2.5 Dermatological OTC Drugs Market Size by Distribution Channel
2.5.1 Dermatological OTC Drugs Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028)
2.5.2 Global Dermatological OTC Drugs Market Size Market Share by Distribution Channel (2017-2022)
3 Dermatological OTC Drugs Market Size by Player
3.1 Dermatological OTC Drugs Market Size Market Share by Players
3.1.1 Global Dermatological OTC Drugs Revenue by Players (2020-2022)
3.1.2 Global Dermatological OTC Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Dermatological OTC Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dermatological OTC Drugs by Regions
4.1 Dermatological OTC Drugs Market Size by Regions (2017-2022)
4.2 Americas Dermatological OTC Drugs Market Size Growth (2017-2022)
4.3 APAC Dermatological OTC Drugs Market Size Growth (2017-2022)
4.4 Europe Dermatological OTC Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Dermatological OTC Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Dermatological OTC Drugs Market Size by Country (2017-2022)
5.2 Americas Dermatological OTC Drugs Market Size by Type (2017-2022)
5.3 Americas Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermatological OTC Drugs Market Size by Region (2017-2022)
6.2 APAC Dermatological OTC Drugs Market Size by Type (2017-2022)
6.3 APAC Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dermatological OTC Drugs by Country (2017-2022)
7.2 Europe Dermatological OTC Drugs Market Size by Type (2017-2022)
7.3 Europe Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermatological OTC Drugs by Region (2017-2022)
8.2 Middle East & Africa Dermatological OTC Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dermatological OTC Drugs Market Forecast
10.1 Global Dermatological OTC Drugs Forecast by Regions (2023-2028)
10.1.1 Global Dermatological OTC Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Dermatological OTC Drugs Forecast
10.1.3 APAC Dermatological OTC Drugs Forecast
10.1.4 Europe Dermatological OTC Drugs Forecast
10.1.5 Middle East & Africa Dermatological OTC Drugs Forecast
10.2 Americas Dermatological OTC Drugs Forecast by Country (2023-2028)
10.2.1 United States Dermatological OTC Drugs Market Forecast
10.2.2 Canada Dermatological OTC Drugs Market Forecast
10.2.3 Mexico Dermatological OTC Drugs Market Forecast
10.2.4 Brazil Dermatological OTC Drugs Market Forecast
10.3 APAC Dermatological OTC Drugs Forecast by Region (2023-2028)
10.3.1 China Dermatological OTC Drugs Market Forecast
10.3.2 Japan Dermatological OTC Drugs Market Forecast
10.3.3 Korea Dermatological OTC Drugs Market Forecast
10.3.4 Southeast Asia Dermatological OTC Drugs Market Forecast
10.3.5 India Dermatological OTC Drugs Market Forecast
10.3.6 Australia Dermatological OTC Drugs Market Forecast
10.4 Europe Dermatological OTC Drugs Forecast by Country (2023-2028)
10.4.1 Germany Dermatological OTC Drugs Market Forecast
10.4.2 France Dermatological OTC Drugs Market Forecast
10.4.3 UK Dermatological OTC Drugs Market Forecast
10.4.4 Italy Dermatological OTC Drugs Market Forecast
10.4.5 Russia Dermatological OTC Drugs Market Forecast
10.5 Middle East & Africa Dermatological OTC Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Dermatological OTC Drugs Market Forecast
10.5.2 South Africa Dermatological OTC Drugs Market Forecast
10.5.3 Israel Dermatological OTC Drugs Market Forecast
10.5.4 Turkey Dermatological OTC Drugs Market Forecast
10.5.5 GCC Countries Dermatological OTC Drugs Market Forecast
10.6 Global Dermatological OTC Drugs Forecast by Type (2023-2028)
10.7 Global Dermatological OTC Drugs Forecast by Distribution Channel (2023-2028)
11 Key Players Analysis
11.1 Perrigo Company plc
11.1.1 Perrigo Company plc Company Information
11.1.2 Perrigo Company plc Dermatological OTC Drugs Product Offered
11.1.3 Perrigo Company plc Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Perrigo Company plc Main Business Overview
11.1.5 Perrigo Company plc Latest Developments
11.2 Bausch Health Companies Inc.
11.2.1 Bausch Health Companies Inc. Company Information
11.2.2 Bausch Health Companies Inc. Dermatological OTC Drugs Product Offered
11.2.3 Bausch Health Companies Inc. Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bausch Health Companies Inc. Main Business Overview
11.2.5 Bausch Health Companies Inc. Latest Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Information
11.3.2 Dr. Reddy's Laboratories Dermatological OTC Drugs Product Offered
11.3.3 Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Dr. Reddy's Laboratories Main Business Overview
11.3.5 Dr. Reddy's Laboratories Latest Developments
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Information
11.4.2 Johnson and Johnson Dermatological OTC Drugs Product Offered
11.4.3 Johnson and Johnson Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson and Johnson Main Business Overview
11.4.5 Johnson and Johnson Latest Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Information
11.5.2 Bayer AG Dermatological OTC Drugs Product Offered
11.5.3 Bayer AG Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer AG Main Business Overview
11.5.5 Bayer AG Latest Developments
11.6 GlaxoSmithKline plc.
11.6.1 GlaxoSmithKline plc. Company Information
11.6.2 GlaxoSmithKline plc. Dermatological OTC Drugs Product Offered
11.6.3 GlaxoSmithKline plc. Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 GlaxoSmithKline plc. Main Business Overview
11.6.5 GlaxoSmithKline plc. Latest Developments
11.7 Viatris Inc
11.7.1 Viatris Inc Company Information
11.7.2 Viatris Inc Dermatological OTC Drugs Product Offered
11.7.3 Viatris Inc Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Viatris Inc Main Business Overview
11.7.5 Viatris Inc Latest Developments
11.8 LEO Pharma A/S
11.8.1 LEO Pharma A/S Company Information
11.8.2 LEO Pharma A/S Dermatological OTC Drugs Product Offered
11.8.3 LEO Pharma A/S Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 LEO Pharma A/S Main Business Overview
11.8.5 LEO Pharma A/S Latest Developments
11.9 Acella Pharmaceuticals, LLC
11.9.1 Acella Pharmaceuticals, LLC Company Information
11.9.2 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Product Offered
11.9.3 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Acella Pharmaceuticals, LLC Main Business Overview
11.9.5 Acella Pharmaceuticals, LLC Latest Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
11.10.2 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Product Offered
11.10.3 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.11 Galderma
11.11.1 Galderma Company Information
11.11.2 Galderma Dermatological OTC Drugs Product Offered
11.11.3 Galderma Dermatological OTC Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Galderma Main Business Overview
11.11.5 Galderma Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Dermatological OTC Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Acne Medications
Table 3. Major Players of Dermatitis Drugs
Table 4. Major Players of Fungal Infection Drugs
Table 5. Dermatological OTC Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Dermatological OTC Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Dermatological OTC Drugs Market Size Market Share by Type (2017-2022)
Table 8. Dermatological OTC Drugs Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 10. Global Dermatological OTC Drugs Market Size Market Share by Distribution Channel (2017-2022)
Table 11. Global Dermatological OTC Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Dermatological OTC Drugs Revenue Market Share by Player (2020-2022)
Table 13. Dermatological OTC Drugs Key Players Head office and Products Offered
Table 14. Dermatological OTC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Dermatological OTC Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Dermatological OTC Drugs Market Size Market Share by Regions (2017-2022)
Table 19. Americas Dermatological OTC Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Dermatological OTC Drugs Market Size Market Share by Country (2017-2022)
Table 21. Americas Dermatological OTC Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Dermatological OTC Drugs Market Size Market Share by Type (2017-2022)
Table 23. Americas Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 24. Americas Dermatological OTC Drugs Market Size Market Share by Distribution Channel (2017-2022)
Table 25. APAC Dermatological OTC Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Dermatological OTC Drugs Market Size Market Share by Region (2017-2022)
Table 27. APAC Dermatological OTC Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Dermatological OTC Drugs Market Size Market Share by Type (2017-2022)
Table 29. APAC Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 30. APAC Dermatological OTC Drugs Market Size Market Share by Distribution Channel (2017-2022)
Table 31. Europe Dermatological OTC Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Dermatological OTC Drugs Market Size Market Share by Country (2017-2022)
Table 33. Europe Dermatological OTC Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Dermatological OTC Drugs Market Size Market Share by Type (2017-2022)
Table 35. Europe Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 36. Europe Dermatological OTC Drugs Market Size Market Share by Distribution Channel (2017-2022)
Table 37. Middle East & Africa Dermatological OTC Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Dermatological OTC Drugs Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Dermatological OTC Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Dermatological OTC Drugs Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Dermatological OTC Drugs Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Dermatological OTC Drugs Market Size Market Share by Distribution Channel (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Dermatological OTC Drugs
Table 44. Key Market Challenges & Risks of Dermatological OTC Drugs
Table 45. Key Industry Trends of Dermatological OTC Drugs
Table 46. Global Dermatological OTC Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Dermatological OTC Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Dermatological OTC Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Dermatological OTC Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Dermatological OTC Drugs Market Size Forecast by Distribution Channel (2023-2028) & ($ Millions)
Table 51. Global Dermatological OTC Drugs Market Size Market Share Forecast by Distribution Channel (2023-2028)
Table 52. Perrigo Company plc Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 53. Perrigo Company plc Dermatological OTC Drugs Product Offered
Table 54. Perrigo Company plc Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Perrigo Company plc Main Business
Table 56. Perrigo Company plc Latest Developments
Table 57. Bausch Health Companies Inc. Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 58. Bausch Health Companies Inc. Dermatological OTC Drugs Product Offered
Table 59. Bausch Health Companies Inc. Main Business
Table 60. Bausch Health Companies Inc. Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bausch Health Companies Inc. Latest Developments
Table 62. Dr. Reddy's Laboratories Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 63. Dr. Reddy's Laboratories Dermatological OTC Drugs Product Offered
Table 64. Dr. Reddy's Laboratories Main Business
Table 65. Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Dr. Reddy's Laboratories Latest Developments
Table 67. Johnson and Johnson Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 68. Johnson and Johnson Dermatological OTC Drugs Product Offered
Table 69. Johnson and Johnson Main Business
Table 70. Johnson and Johnson Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Johnson and Johnson Latest Developments
Table 72. Bayer AG Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 73. Bayer AG Dermatological OTC Drugs Product Offered
Table 74. Bayer AG Main Business
Table 75. Bayer AG Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Bayer AG Latest Developments
Table 77. GlaxoSmithKline plc. Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 78. GlaxoSmithKline plc. Dermatological OTC Drugs Product Offered
Table 79. GlaxoSmithKline plc. Main Business
Table 80. GlaxoSmithKline plc. Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. GlaxoSmithKline plc. Latest Developments
Table 82. Viatris Inc Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 83. Viatris Inc Dermatological OTC Drugs Product Offered
Table 84. Viatris Inc Main Business
Table 85. Viatris Inc Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Viatris Inc Latest Developments
Table 87. LEO Pharma A/S Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 88. LEO Pharma A/S Dermatological OTC Drugs Product Offered
Table 89. LEO Pharma A/S Main Business
Table 90. LEO Pharma A/S Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. LEO Pharma A/S Latest Developments
Table 92. Acella Pharmaceuticals, LLC Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 93. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Product Offered
Table 94. Acella Pharmaceuticals, LLC Main Business
Table 95. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Acella Pharmaceuticals, LLC Latest Developments
Table 97. Teva Pharmaceutical Industries Ltd. Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 98. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Product Offered
Table 99. Teva Pharmaceutical Industries Ltd. Main Business
Table 100. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 102. Galderma Details, Company Type, Dermatological OTC Drugs Area Served and Its Competitors
Table 103. Galderma Dermatological OTC Drugs Product Offered
Table 104. Galderma Dermatological OTC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Galderma Main Business
Table 106. Galderma Latest Developments
List of Figures
Figure 1. Dermatological OTC Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dermatological OTC Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Dermatological OTC Drugs Market Size Market Share by Type in 2021
Figure 7. Dermatological OTC Drugs in Online Distribution
Figure 8. Global Dermatological OTC Drugs Market: Online Distribution (2017-2022) & ($ Millions)
Figure 9. Dermatological OTC Drugs in Offline Distribution
Figure 10. Global Dermatological OTC Drugs Market: Offline Distribution (2017-2022) & ($ Millions)
Figure 11. Global Dermatological OTC Drugs Market Size Market Share by Distribution Channel in 2021
Figure 12. Global Dermatological OTC Drugs Revenue Market Share by Player in 2021
Figure 13. Global Dermatological OTC Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Dermatological OTC Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Dermatological OTC Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Dermatological OTC Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Dermatological OTC Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Dermatological OTC Drugs Value Market Share by Country in 2021
Figure 19. Americas Dermatological OTC Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Dermatological OTC Drugs Market Size Market Share by Distribution Channel in 2021
Figure 21. United States Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Dermatological OTC Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Dermatological OTC Drugs Market Size Market Share by Distribution Channel in 2021
Figure 27. China Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Dermatological OTC Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Dermatological OTC Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Dermatological OTC Drugs Market Size Market Share by Distribution Channel in 2021
Figure 36. Germany Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Dermatological OTC Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Dermatological OTC Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Dermatological OTC Drugs Market Size Market Share by Distribution Channel in 2021
Figure 44. Egypt Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Dermatological OTC Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Dermatological OTC Drugs Market Size 2023-2028 ($ Millions)